The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens
Abstract
Pregabalin binds with high affinity to the alpha2-delta subunit protein of voltage-gated calcium channels and, thereby, reduces release of excitatory neurotransmitters. This 12-week randomised, double-blind, multicentre, placebo-controlled, parallel-group study evaluated the efficacy and safety of pregabalin in patients with chronic postherpetic neuralgia (PHN) or painful diabetic peripheral neuropathy (DPN). Patients were randomised to placebo (n=65) or to one of two pregabalin regimens: a flexible schedule of 150, 300, 450, and 600 mg/day with weekly dose escalation based on patients' individual responses and tolerability (n=141) or a fixed schedule of 300 mg/day for 1 week followed by 600 mg/day for 11 weeks (n=132). Both flexible- and fixed-dose pregabalin significantly reduced endpoint mean pain score (primary outcome) versus placebo (P=0.002, P<0.001) and were significantly superior to placebo in improving pain-related sleep interference (P<0.001). The most common adverse events (AEs) for pregabalin-treated patients were dizziness, peripheral oedema, weight gain (not affecting diabetes control), and somnolence. These results are consistent with previous studies' demonstrating pregabalin's efficacy, tolerability, and safety for treatment of chronic neuropathic pain associated with DPN or PHN. Pregabalin dosing aimed at optimal balance of efficacy and tolerability provides significant pain relief and may reduce risks for AEs and therapy discontinuation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
Neuropathic pain: aetiology, symptoms, mechanisms, and management
Woolf, C. J., & Mannion, R. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01307-0 · Cited by 2,230
Backonja, M. (1998) · JAMA · doi:10.1001/jama.280.21.1831 · Cited by 1,533
Rowbotham, M. (1998) · JAMA · doi:10.1001/jama.280.21.1837 · Cited by 1,433
The Management of Persistent Pain in Older Persons: AGS Panel on Persistent Pain in Older Persons
(2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.50.6s.1.x · Cited by 1,139
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial
Dworkin, R. H., Corbin, A. E., Young, J. P., Sharma, U., LaMoreaux, L., Bockbrader, H., Garofalo, E. A., & Poole, R. M. (2003) · Neurology · doi:10.1212/01.wnl.0000055433.55136.55 · Cited by 768
Rosenstock, J., Tuchman, M., LaMoreaux, L., & Sharma, U. (2004) · Pain · doi:10.1016/j.pain.2004.05.001 · Cited by 725
Assessing the clinical significance of change scores recorded on subjective outcome measures
Hurst, H., & Bolton, J. (2004) · Journal of Manipulative and Physiological Therapeutics · doi:10.1016/j.jmpt.2003.11.003 · Cited by 702
Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention
Kost, R. G., & Straus, S. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350107 · Cited by 641
Luo, Z. D., Chaplan, S. R., Higuera, E. S., Sorkin, L. S., Stauderman, K. A., Williams, M. E., & Yaksh, T. L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01868.2001 · Cited by 616
Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial
Lesser, H., Sharma, U., LaMoreaux, L., & Poole, R. M. (2004) · Neurology · doi:10.1212/01.wnl.0000145767.36287.a1 · Cited by 570
Epidemiology and Impact on Quality of Life of Postherpetic Neuralgia and Painful Diabetic Neuropathy
Schmader, K. E. (2002) · The Clinical Journal of Pain · doi:10.1097/00002508-200211000-00002 · Cited by 550
Sabatowski, R., Gálvez, R., Cherry, D. A., Jacquot, F., Vincent, E., Maisonobe, P., & Versavel, M. (2004) · Pain · doi:10.1016/j.pain.2004.01.001 · Cited by 527
Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex
Fink, K., Dooley, D. J., Meder, W. P., Suman-Chauhan, N., Duffy, S., Clusmann, H., & Göthert, M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00172-1 · Cited by 496
Richter, R. W., Portenoy, R., Sharma, U., Lamoreaux, L., Bockbrader, H., & Knapp, L. E. (2005) · The Journal of Pain · doi:10.1016/j.jpain.2004.12.007 · Cited by 473
Measuring Functioning and Well-Being
Stewart, A., & Ware, J. E. (1992) · Cited by 458
Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials
Backonja, M., & Glanzman, R. L. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)90011-7 · Cited by 425
Pain and its persistence in herpes zoster
Dworkin, R. H., & Portenoy, R. K. (1996) · Pain · doi:10.1016/0304-3959(96)03122-3 · Cited by 396
Dubinsky, R. M., Kabbani, H., El-Chami, Z., Boutwell, C., & Ali, H. (2004) · Neurology · doi:10.1212/01.wnl.0000140708.62856.72 · Cited by 300
Field, M. J., McCleary, S., Hughes, J., & Singh, L. (1999) · Pain · doi:10.1016/s0304-3959(98)00239-5 · Cited by 295
Peripheral neuropathic pain—a multidimensional burden for patients
Meyer‐Rosberg, K., Kvarnström, A., Kinnman, E., Gordh, T., Nordfors, L., & Kristofferson, A. (2001) · European Journal of Pain · doi:10.1053/eujp.2001.0259 · Cited by 247
Risk Factors for Postherpetic Neuralgia
Choo, P. W. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.11.1217 · Cited by 229
Maneuf, Y. P., Hughes, J., & McKnight, A. T. (2001) · Pain · doi:10.1016/s0304-3959(01)00316-5 · Cited by 184
Dooley, D. J., Donovan, C. M., Meder, W. P., & Whetzel, S. Z. (2002) · Synapse · doi:10.1002/syn.10094 · Cited by 180
Potential mechanisms of neuropathic pain in diabetes
Calcutt, N. A. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)50078-7 · Cited by 161
Understanding the impact of painful diabetic neuropathy
Quattrini, C., & Tesfaye, S. H. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.360 · Cited by 140
Wallin, J., Cui, J., Yakhnitsa, V., Schechtmann, G., Meyerson, B. A., & Linderoth, B. (2002) · European Journal of Pain · doi:10.1053/eujp.2002.0329 · Cited by 124
Antidepressants in the Management of Chronic Pain Syndromes
Egbunike, I. G., & Chaffee, B. J. (1990) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1990.tb02582.x · Cited by 116
Diop, L., Raymond, F., Fargeau, H., Pétoux, F., Chovet, M., & Doherty, A. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.3.1013 · Cited by 94
What Is a Meaningful Pain Reduction in Patients With Complex Regional Pain Syndrome Type 1?
Forouzanfar, T., Weber, W. E. J., Kemler, M. A., & van Kleef, M. (2003) · Clinical Journal of Pain · doi:10.1097/00002508-200309000-00001 · Cited by 88
Treatment of Postherpetic Neuralgia
Kanazi, G. E., Johnson, R. W., & Dworkin, R. H. (2000) · Drugs · doi:10.2165/00003495-200059050-00007 · Cited by 84
Chen, S.-R., Xu, Z., & Pan, H. (2001) · Anesthesiology · doi:10.1097/00000542-200112000-00029 · Cited by 74
Slowing the Initial Titration Rate of Tramadol Improves Tolerability
RUOFF, G. E. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.1.88.30515 · Cited by 72
Antinociceptive Effect of Pregabalin in Septic Shock-Induced Rectal Hypersensitivity in Rats
Eutamène, H., Coelho, A.-M., Théodorou, V., Toulouse, M., Chovet, M., Doherty, A. M., Fioramonti, J., & Bueno, L. P. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38882-2 · Cited by 59
The management of postherpetic neuralgia
Bowsher, D. (1997) · Postgraduate Medical Journal · doi:10.1136/pgmj.73.864.623 · Cited by 56
Sabatowski, R., Gálvez, R., Cherry, D. A., Jacquot, F., & Versavel, M. (2004) · Journal of Pain · doi:10.1016/j.jpain.2004.02.195 · Cited by 42
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40
Risk-Benefit Assessment of Carbamazepine in Children
Seetharam, M. N., & Pellock, J. M. (1991) · Drug Safety · doi:10.2165/00002018-199106020-00005 · Cited by 28
Review of the Symptomatic Treatment of Diabetic Neuropathy
Wright, J. (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb04161.x · Cited by 27
Cited by
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Mechanisms of neuropathic pain
Campbell, J. N., & Meyer, R. A. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.021 · Cited by 1,471
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Metadata
- Authors
- Freynhagen, R., Strojek, K., Griesing, T., Whalen, E., & Balkenohl, M.
- Venue
- Pain
- Published
- 2005-06
- Volume
- 115
- Issue
- 3
- Pages
- 254-263
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2159977024
- Cited by
- 572
- References
- 40
- FWCI
- 29.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.